idoxuridine has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 1 studies
Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mathematical models of cancer relevant processes are being developed at an increasing rate." | 1.33 | On systems and control approaches to therapeutic gain. ( Jackson, RC; Loparo, KA; Radivoyevitch, T; Sedwick, WD, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Radivoyevitch, T | 1 |
| Loparo, KA | 1 |
| Jackson, RC | 1 |
| Sedwick, WD | 1 |
1 other study available for idoxuridine and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
On systems and control approaches to therapeutic gain.
Topics: Antineoplastic Agents; Core Binding Factor Alpha 2 Subunit; DNA Repair; DNA, Neoplasm; Drug Resistan | 2006 |